A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination with Dapagliflozin on CKD Progression in Participants with CKD and High Blood Pressure.

Protocol Name: A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination with Dapagliflozin on CKD Progression in Participants with CKD and High Blood Pressure.

Sponsor: AstraZeneca

Indication: CKD & HTN

GFR: 30-89

Principal Investigator: Ankit Mehta, MD

Location: Landry Center, 411 N. Washington Ave, Suite #6000, Dallas, TX 75246

DETAILS >